Gene Page: CDSN
Summary ?
GeneID | 1041 |
Symbol | CDSN |
Synonyms | HTSS|HTSS1|HYPT2|PSS|PSS1|S |
Description | corneodesmosin |
Reference | MIM:602593|HGNC:HGNC:1802|Ensembl:ENSG00000204539|HPRD:03998|Vega:OTTHUMG00000031150 |
Gene type | protein-coding |
Map location | 6p21.3 |
Pascal p-value | 2.073E-7 |
eGene | Myers' cis & trans |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
GSMA_I | Genome scan meta-analysis | Psr: 0.033 |
Section I. Genetics and epigenetics annotation
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs16869851 | chr4 | 20690056 | CDSN | 1041 | 0.17 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
CKAP2 | 0.83 | 0.83 |
MYO3A | 0.82 | 0.48 |
ATAD2 | 0.81 | 0.79 |
C14orf106 | 0.81 | 0.73 |
SGOL2 | 0.81 | 0.78 |
CENPC1 | 0.79 | 0.77 |
MLF1IP | 0.79 | 0.47 |
SMARCA5 | 0.79 | 0.81 |
SMC2 | 0.79 | 0.76 |
RDX | 0.79 | 0.76 |
Top 10 negatively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
AF347015.31 | -0.42 | -0.64 |
CXCL14 | -0.41 | -0.63 |
MT-CO2 | -0.41 | -0.64 |
AF347015.2 | -0.41 | -0.62 |
AF347015.8 | -0.40 | -0.62 |
MT-CYB | -0.40 | -0.61 |
IFI27 | -0.39 | -0.63 |
AF347015.33 | -0.39 | -0.58 |
COX4I2 | -0.38 | -0.59 |
AF347015.15 | -0.38 | -0.60 |
Section III. Gene Ontology annotation
Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0003674 | molecular_function | ND | - | |
GO:0016740 | transferase activity | IEA | - | |
GO:0042803 | protein homodimerization activity | IDA | 15086562 | |
Biological process | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0008544 | epidermis development | TAS | 9395522 | |
GO:0008152 | metabolic process | IEA | - | |
GO:0016337 | cell-cell adhesion | IDA | 11739386 | |
GO:0030216 | keratinocyte differentiation | NAS | 8415725 | |
Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0001533 | cornified envelope | IDA | 9395522 | |
GO:0005576 | extracellular region | IEA | - | |
GO:0030057 | desmosome | NAS | 9395522 |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
BERENJENO ROCK SIGNALING NOT VIA RHOA UP | 29 | 21 | All SZGR 2.0 genes in this pathway |
GAUSSMANN MLL AF4 FUSION TARGETS E DN | 22 | 12 | All SZGR 2.0 genes in this pathway |
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY DN | 382 | 224 | All SZGR 2.0 genes in this pathway |
RICKMAN TUMOR DIFFERENTIATED WELL VS MODERATELY DN | 110 | 64 | All SZGR 2.0 genes in this pathway |
RICKMAN HEAD AND NECK CANCER C | 113 | 47 | All SZGR 2.0 genes in this pathway |
TARTE PLASMA CELL VS PLASMABLAST UP | 398 | 262 | All SZGR 2.0 genes in this pathway |
SMITH TERT TARGETS DN | 87 | 69 | All SZGR 2.0 genes in this pathway |
MAGRANGEAS MULTIPLE MYELOMA IGLL VS IGLK DN | 24 | 18 | All SZGR 2.0 genes in this pathway |
PYEON CANCER HEAD AND NECK VS CERVICAL DN | 29 | 11 | All SZGR 2.0 genes in this pathway |
KIM BIPOLAR DISORDER OLIGODENDROCYTE DENSITY CORR DN | 88 | 59 | All SZGR 2.0 genes in this pathway |
PILON KLF1 TARGETS UP | 504 | 321 | All SZGR 2.0 genes in this pathway |
ZWANG TRANSIENTLY UP BY 1ST EGF PULSE ONLY | 1839 | 928 | All SZGR 2.0 genes in this pathway |